Advanced search
Publication Cover
Cytotherapy Volume 3, 2001 - Issue 6
Journal homepage
13
Views
4
CrossRef citations to date
0
Altmetric
Research Article

CD34 selection using three immunoselection devices: comparison of T-cell depleted allografts

PV O'Donnell Division of Hematologic Malignancies, The Johns Hopkins Oncology Center Baltimore, MD, USA
,
B Myers Division of Hematologic Malignancies, The Johns Hopkins Oncology Center Baltimore, MD, USA
,
J Edwards Division of Hematologic Malignancies, The Johns Hopkins Oncology Center Baltimore, MD, USA
,
K Loper Division of Hematologic Malignancies, The Johns Hopkins Oncology Center Baltimore, MD, USA
,
P Rhubart Division of Hematologic Malignancies, The Johns Hopkins Oncology Center Baltimore, MD, USA
&
SJ Noga Division of Hematologic Malignancies, The Johns Hopkins Oncology Center Baltimore, MD, USA
Pages 483-488 | Published online: 07 Jul 2009

  • Kernan NA. T-cell depletion for the prevention of graft-versus-host disease. In: Thomas ED, Blume KG, Forman SJ, editors. Hematopoietic cell transplantation. Malden: Blackwell Science, Inc., 1999: 186-96.
  • ODonnell PV, Jones RJ, Vogelsang GB et al. CD341 stem cell augmentation of elutriated, allogeneic bone marrow grafts: Results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies. Bone Marrow Transplant 1998;22:947-55.
  • Jones RJ, Wagner JE, Celano P, Zicha MS. Separation of pluripotent hematopoietic stem cells from multipotent progenitors (CFU-S). Nature 1990;347:188-8.
  • Gao IK, Noga SJ, Wagner JE et al. Implementation of a semiclosed large scale counterflow centrifugal elutriation system J Clin Apheresis 1987;3:154-60.
  • Wagner JE, Santos GW, Noga SJ et al. Bone marrow graft engineering by counterflow cenfrifugal elutriation: results of a Phase I-II clinical trial. Blood 1990;75:1370-7.
  • Wagner JE, Donnenberg AD, Noga SJ et al. Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a Phase I clinical trial. Blood 1988; 72:1168-76.
  • Trischmann TM, Schepers KG, Civin CI. Measurement of CD341 cells in bone marrow by flow cytometry. J Hematother 1993;2:305-13.
  • Sutherland DR, Anderson L, Keeney M et al. The ISHAGE guidelines for CD341 cell determination by flow cytometry. J Hematother 1996;5:213-26.
  • Rowley SD, Zuehldorf M, Braine HG, Colvin OM. CFU-GM content of bone marrow graft correlates with time to hematologic reconstitution following autologus bone marrow transplantation with 4-hydroperoxycyclophosphamide-purged bone marrow. Blood 1987;70:271-275.
  • Curtis RE, Travis LB, Rowlings PA et al. Risk of lympho-proliferative disorders after bone marrow transplantation: A multi-institutional study. Blood 1999;94:2208-16.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.